Organisation: State Administration for Market Regulation (China)

China’s competition watchdog has released guidelines spelling out how it will enforce the country’s antitrust rules after lawmakers amended the legislation last year, although local lawyers say the agency has deleted key clarifications from the final versions.

27 March 2023

China’s competition watchdog has fined a drugmaker nearly €3.7 million for hiking the price of a “gold standard” cancer treatment by 750% despite production costs allegedly remaining stable.

23 March 2023

Featured in Asia-Pacific Antitrust Review 2023

Asia-Pacific regulators are increasingly shining a light on antitrust violations in the pharmaceuticals industry, with stiffer penalties for cartel conduct, abuse of dominance and anticompetitive agreements.

10 March 2023

Featured in Asia-Pacific Antitrust Review 2023

The year 2022 was a landmark 12 months for China’s anti-monopoly regime. The adoption of amendments to the Anti-monopoly Law coincided with the release of the State Administration for Market Regulation and the Supreme People’s Court’s draft revisions to various antitrust rules, significantly reshaping the landscape.

10 March 2023

Featured in Asia-Pacific Antitrust Review 2023

Amid ambitious monetisation efforts, and alongside fierce competition for users and their data, the relationship between competition law and data privacy is proving pivotal in the region. Going forward, regulating enforcement against Big Tech and harmonising data privacy regimes will be essential.

10 March 2023

China’s antitrust authority has fined a domestic pharmaceutical company €18.1 million for abusing its dominance by hiking the price of an active pharmaceutical ingredient by nearly 400%.

21 February 2023

China’s antitrust watchdog has fined an online academic literature database €12.1 million for abusing its dominance by imposing excessively high subscription fees and forcing users into exclusivity arrangements.

09 January 2023

China’s competition watchdog has fined the local subsidiary of medical device maker Straumann €4.7 million for fixing the resale price of dental implants and punishing distributors that failed to follow the agreement.

04 January 2023

China’s antitrust authority has cleared Korean Air’s proposed €1.3 billion majority investment in Asiana Airlines with a mix of structural and behavioural remedies, ending an in-depth merger review that lasted nearly two years.

03 January 2023

China’s antitrust agency has penalised three civil explosives manufacturers, an exclusive distributor and a trade association more than €7.1 million for participating in a cartel that included horizontal collusion and resale price maintenance.

20 December 2022